2024-10-22 07:59:05
Henlius' 4th Biologics: Bevacizumab Biosimilar Hanbeitai Approved by National Medical Products Administration
Corporate/ 2023-07-23
Henlius' 4th Biologics: Bevacizumab...

SHANGHAI,Dec. 4,2021-- Shanghai Henlius Biotech,Inc. (2696.HK) announced that bevacizumab biosimilar Hanbeitai,developed and manufactured by...

Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma
Corporate/ 2023-07-23
Kazia Announces Positive Final Data From...

SYDNEY,Dec. 4,2021--Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA),an oncology-focused drug development company,is pleased to announce ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release